Overview of the Abilify Mass Tort
The Abilify mass tort represents a significant legal challenge against Bristol-Myers Squibb and Otsuka Pharmaceutical, the manufacturers of Abilify (Aripiprazole). This prescription medication, widely used to treat psychological disorders such as schizophrenia, bipolar disorder, and major depression, has been linked to serious side effects that were not adequately disclosed to patients or healthcare providers. Since its FDA approval in 2002, millions have used Abilify, but it took nearly a decade to recognize its association with impulse control disorders. This oversight has led to over 2,600 lawsuits, culminating in a massive litigation effort to hold the manufacturers accountable for the emotional and financial damages suffered by patients.
Call Us